Zobrazeno 1 - 10
of 25
pro vyhledávání: '"José Antonio García-Marco"'
Autor:
Pau Abrisqueta, Eva González-Barca, Christelle Ferrà, Eduardo Ríos-Herranz, Margarita Fernández de la Mata, Julio Delgado, Rafael Andreu, José Ángel Hernández-Rivas, María José Terol, Almudena Navarro, M. Belén Vidriales, Patricia Baltasar, Javier De la Serna, Ángel Ramírez, Carmen Ballester, Carol Moreno, José Antonio García-Marco, Raúl Córdoba, Lucrecia Yáñez, Luís Felipe Casado, Marcos González, Francesc Bosch
Publikováno v:
EClinicalMedicine, Vol 73, Iss , Pp 102642- (2024)
Summary: Background: BTK inhibitors have been concurrently administered with anti-CD20 monoclonal antibodies (mAbs) in chronic lymphocytic leukemia (CLL). However, the optimal regimen for combining these two drugs remains pending. Methods: This multi
Externí odkaz:
https://doaj.org/article/0409832eb56e42f09c46046064da1b29
Autor:
Javier Loscertales, Pau Abrisqueta-Costa, Antonio Gutierrez, José Ángel Hernández-Rivas, Rafael Andreu-Lapiedra, Alba Mora, Carolina Leiva-Farré, María Dolores López-Roda, Ángel Callejo-Mellén, Esther Álvarez-García, José Antonio García-Marco
Publikováno v:
Cancers, Vol 15, Iss 16, p 4047 (2023)
The SRealCLL study aimed to obtain real-world evidence on the clinical characteristics and treatment patterns of patients with chronic lymphocytic leukemia (CLL) using natural language processing (NLP). Electronic health records (EHRs) from seven Spa
Externí odkaz:
https://doaj.org/article/1fb0dc93a2f14031b3586ae944d20af1
Autor:
Isabel Jiménez, Bárbara Tazón-Vega, Pau Abrisqueta, Juan C. Nieto, Sabela Bobillo, Carles Palacio-García, Júlia Carabia, Rafael Valdés-Mas, Magdalena Munuera, Lluís Puigdefàbregas, Genís Parra, Anna Esteve-Codina, Clara Franco-Jarava, Gloria Iacoboni, María José Terol, José Antonio García-Marco, Marta Crespo, Francesc Bosch
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-14 (2021)
Abstract Background Mechanisms driving the progression of chronic lymphocytic leukemia (CLL) from its early stages are not fully understood. The acquisition of molecular changes at the time of progression has been observed in a small fraction of pati
Externí odkaz:
https://doaj.org/article/b8be7bd26b3d4fcf833809c39c3cd6a1
Autor:
Julia Suárez-González, Juan Carlos Triviño, Guiomar Bautista, José Antonio García-Marco, Ángela Figuera, Antonio Balas, José Luis Vicario, Francisco José Ortuño, Raúl Teruel, José María Álamo, Diego Carbonell, Cristina Andrés-Zayas, Nieves Dorado, Gabriela Rodríguez-Macías, Mi Kwon, José Luis Díez-Martín, Carolina Martínez-Laperche, Ismael Buño, Spanish Group for Hematopoietic Transplantation (GETH)
Publikováno v:
Haematologica, Vol 105, Iss 11 (2020)
Externí odkaz:
https://doaj.org/article/f8e61dd3cfc74a3285178aeb1c206c35
Autor:
Diego Velasco-Rodríguez, Miguel Piris-Villaespesa, Carmen Soteras, Ana Vallés, José Antonio García-Marco, José Antonio García-Vela
Publikováno v:
Case Reports in Hematology, Vol 2017 (2017)
Chronic lymphocytic leukemia (CLL) is an incurable lymphoproliferative disorder with a heterogeneous genetic and clinical course. Two kinase inhibitors, ibrutinib and idelalisib, have demonstrated achievement of complete and durable remissions in rel
Externí odkaz:
https://doaj.org/article/7e59accaef964db983d027d58e869d4c
Autor:
Lindsey E. Roeker, Toby A. Eyre, Meghan C. Thompson, Nicole Lamanna, Alexander R. Coltoff, Matthew S. Davids, Peter O. Baker, Lori Leslie, Kerry A. Rogers, John N. Allan, Raul Cordoba, Alberto Lopez-Garcia, Darko Antic, John M. Pagel, Nicolas Martinez-Calle, José Antonio García-Marco, Jose-Ángel Hernández-Rivas, Fatima Miras, Catherine C. Coombs, Anders Österborg, Lotta Hansson, Amanda N. Seddon, Javier López Jiménez, Matthew R. Wilson, Dima El-Sharkawi, Daniel Wojenski, Shuo Ma, Talha Munir, Susana Valenciano, Erlene Seymour, Paul M. Barr, Jeffrey Pu, Piers E. M. Patten, Guilherme F. Perini, Scott F. Huntington, Helen Parry, Suchitra Sundaram, Alan Skarbnik, Manali Kamdar, Ryan Jacobs, Harriet Walter, Renata Walewska, Angus Broom, Sonia Lebowitz, Krista M. Isaac, Craig A. Portell, Inhye E. Ahn, Chaitra S. Ujjani, Mazyar Shadman, Sigrid S. Skånland, Elise A. Chong, Anthony R. Mato
Publikováno v:
Blood
Autor:
Carlos de Miguel, Ferran Briansó, Rosalia Alonso Trillo, Lucía Nuñez Martín-Buitrago, María Esther Martínez-Muñoz, Guiomar Bautista, Carlos Manchado-Perdiguero, José Antonio García-Marco, Ali Sánchez-Peral, Rafael F. Duarte
Publikováno v:
Transplantation and Cellular Therapy. 29:S66-S67
Autor:
null Julia Suárez-González, null Juan Carlos Triviño, null Guiomar Bautista, null José Antonio García-Marco, null Ángela Figuera, null Antonio Balas, null José Luis Vicario, null Francisco José Ortuño, null Raúl Teruel, null José María Álamo, null Diego Carbonell, null Cristina Andrés-Zayas, null Nieves Dorado, null Gabriela Rodríguez-Macías, null Mi Kwon, null José Luis Díez-Martín, null Carolina Martínez-Laperche, null Ismael Buño, null Spanish Group for Hematopoietic Transplantation (GETH)
Publikováno v:
Haematologica
Publikováno v:
Medicina Clínica. 150:144-149
Resumen La evaluacion de la enfermedad minima residual (EMR) es un objetivo importante en el tratamiento de la leucemia linfocitica cronica (LLC). Su obtencion es predictiva de una supervivencia libre de progresion (SLP) y una supervivencia global pr
Publikováno v:
Medicina clinica. 150(4)
Minimal residual disease (MRD) assessment is an important endpoint in the treatment of chronic lymphocytic leukaemia (CLL). It is highly predictive of prolonged progression-free survival (PFS) and overall survival and could be considered a surrogate